{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:13:28Z","timestamp":1786785208635,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004820","name":"Mochida Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012834","name":"Gifu University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012834","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12325-025-03397-z","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:50:39Z","timestamp":1761299439000},"page":"6248-6260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8903-3574","authenticated-orcid":false,"given":"Kyoko","family":"Kikuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-1272","authenticated-orcid":false,"given":"Ryuta","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1979-8310","authenticated-orcid":false,"given":"Takuma","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7869-1428","authenticated-orcid":false,"given":"Ken-ichirou","family":"Morishige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8839-4483","authenticated-orcid":false,"given":"Kenro","family":"Chikazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-219X","authenticated-orcid":false,"given":"Tatsuro","family":"Furui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5899-9932","authenticated-orcid":false,"given":"Masanori","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"3397_CR1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1210\/er.2018-00242","volume":"40","author":"SE Bulun","year":"2019","unstructured":"Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40:1048\u201379. https:\/\/doi.org\/10.1210\/er.2018-00242.","journal-title":"Endocr Rev"},{"key":"3397_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.fertnstert.2011.04.095","volume":"96","author":"J Fourquet","year":"2011","unstructured":"Fourquet J, B\u00e1ez L, Figueroa M, Iriarte RI, Flores I. Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril. 2011;96:107\u201312. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.04.095.","journal-title":"Fertil Steril"},{"key":"3397_CR3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/01.AOG.0000142714.54857.f8","volume":"104","author":"SA Missmer","year":"2004","unstructured":"Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Malspeis S, Willett WC, et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol. 2004;104:965\u201374. https:\/\/doi.org\/10.1097\/01.AOG.0000142714.54857.f8.","journal-title":"Obstet Gynecol"},{"key":"3397_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejogrb.2016.04.021","volume":"209","author":"F Parazzini","year":"2017","unstructured":"Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur J Obstet Gynecol Reprod Biol. 2017;209:3\u20137. https:\/\/doi.org\/10.1016\/j.ejogrb.2016.04.021.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3397_CR5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3111\/13696998.2013.830974","volume":"16","author":"E Tanaka","year":"2013","unstructured":"Tanaka E, Momoeda M, Osuga Y, et al. Burden of menstrual symptoms in Japanese women: results from a survey-based study. J Med Econ. 2013;16:1255\u201366. https:\/\/doi.org\/10.3111\/13696998.2013.830974.","journal-title":"J Med Econ"},{"key":"3397_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jpag.2017.01.014","volume":"30","author":"AD Ebert","year":"2017","unstructured":"Ebert AD, Dong L, Merz M, et al. Dienogest 2 mg daily in the treatment of adolescents with clinically suspected endometriosis: the VISanne study to assess safety in ADOlescents. J Pediatr Adolesc Gynecol. 2017;30:560\u20137. https:\/\/doi.org\/10.1016\/j.jpag.2017.01.014.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"3397_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/03007995.2020.1744120","volume":"36","author":"A Murji","year":"2020","unstructured":"Murji A, Bibero\u011flu K, Leng J, et al. Use of dienogest in endometriosis: a narrative literature review and expert commentary. Curr Med Res Opin. 2020;36:895\u2013907. https:\/\/doi.org\/10.1080\/03007995.2020.1744120.","journal-title":"Curr Med Res Opin"},{"key":"3397_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00404-011-1941-7","volume":"285","author":"F Petraglia","year":"2012","unstructured":"Petraglia F, Hornung D, Seitz C, et al. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet. 2012;285:167\u201373. https:\/\/doi.org\/10.1007\/s00404-011-1941-7.","journal-title":"Arch Gynecol Obstet"},{"key":"3397_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/humrep\/dep469","volume":"25","author":"T Strowitzki","year":"2010","unstructured":"Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 2010;25:633\u201341. https:\/\/doi.org\/10.1093\/humrep\/dep469.","journal-title":"Hum Reprod"},{"key":"3397_CR10","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/2047487318774847","volume":"25","author":"M Glisic","year":"2018","unstructured":"Glisic M, Shahzad S, Tsoli S, et al. Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis. Eur J Prev Cardiol. 2018;25:1042\u201352. https:\/\/doi.org\/10.1177\/2047487318774847.","journal-title":"Eur J Prev Cardiol"},{"key":"3397_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4944","volume":"345","author":"S Mantha","year":"2012","unstructured":"Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ. 2012;345:e4944. https:\/\/doi.org\/10.1136\/bmj.e4944.","journal-title":"BMJ"},{"key":"3397_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.fertnstert.2019.11.010","volume":"113","author":"Y Osuga","year":"2020","unstructured":"Osuga Y, Hayashi K, Kanda S. A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg\/day in patients with primary and secondary dysmenorrhea. Fertil Steril. 2020;113:627-635.e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.11.010.","journal-title":"Fertil Steril"},{"issue":"4","key":"3397_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/jog.14209","volume":"46","author":"Y Osuga","year":"2020","unstructured":"Osuga Y, Hayashi K, Kanda S. Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea. J Obstet Gynaecol Res. 2020;46(4):606\u201317. https:\/\/doi.org\/10.1111\/jog.14209.","journal-title":"J Obstet Gynaecol Res"},{"key":"3397_CR14","doi-asserted-by":"publisher","DOI":"10.2196\/66246","volume":"14","author":"K Kikuno","year":"2025","unstructured":"Kikuno K, Asada R, Ishihara T, et al. Evaluating the efficacy and safety of 48-week low-dose dienogest administration in patients with dysmenorrhea caused by endometriosis: protocol for a randomized, open-label, parallel-group trial. JMIR Res Protoc. 2025;14:e66246. https:\/\/doi.org\/10.2196\/66246.","journal-title":"JMIR Res Protoc"},{"key":"3397_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"key":"3397_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"3397_CR17","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","volume":"90","author":"T Harada","year":"2008","unstructured":"Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008;90:1583\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.08.051.","journal-title":"Fertil Steril"},{"key":"3397_CR18","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.fertnstert.2011.02.045","volume":"95","author":"T Harada","year":"2011","unstructured":"Harada T, Momoeda M, Terakawa N, Taketani Y, Hoshiai H. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2011;95:1928\u201331. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.02.045.","journal-title":"Fertil Steril"},{"key":"3397_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.fertnstert.2019.09.014","volume":"113","author":"Y Osuga","year":"2020","unstructured":"Osuga Y, Hayashi K, Kanda S. Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study. Fertil Steril. 2020;113:167\u201375. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.09.014.","journal-title":"Fertil Steril"},{"key":"3397_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/09513590.2019.1640674","volume":"36","author":"S Angioni","year":"2020","unstructured":"Angioni S, Pontis A, Malune ME, et al. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol. 2020;36:84\u20136. https:\/\/doi.org\/10.1080\/09513590.2019.1640674.","journal-title":"Gynecol Endocrinol"},{"key":"3397_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","volume":"91","author":"T Harada","year":"2009","unstructured":"Harada T, Momoeda M, Taketani Y, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis\u2014a randomized, double-blind, multicenter, controlled trial. Fertil Steril. 2009;91:675\u201381. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.12.080.","journal-title":"Fertil Steril"},{"key":"3397_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2402942","volume":"56","author":"Y Huang","year":"2024","unstructured":"Huang Y, Zhang D, Zhang L, Zhou Y, Peng C. Clinical efficacy of dienogest against endometriomas with a maximum diameter of \u22654 cm. Ann Med. 2024;56:2402942. https:\/\/doi.org\/10.1080\/07853890.2024.2402942.","journal-title":"Ann Med"},{"key":"3397_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/09513590.2019.1640199","volume":"36","author":"L Muzii","year":"2020","unstructured":"Muzii L, Galati G, Di Tucci C, et al. Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecol Endocrinol. 2020;36:81\u20133. https:\/\/doi.org\/10.1080\/09513590.2019.1640199.","journal-title":"Gynecol Endocrinol"},{"key":"3397_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/09513590.2020.1725965","volume":"36","author":"M Vignali","year":"2020","unstructured":"Vignali M, Belloni GM, Pietropaolo G, et al. Effect of dienogest therapy on the size of the endometrioma. Gynecol Endocrinol. 2020;36:723\u20137. https:\/\/doi.org\/10.1080\/09513590.2020.1725965.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"3397_CR25","first-page":"287","volume":"43","author":"RL Barbieri","year":"1998","unstructured":"Barbieri RL. Endometriosis and the estrogen threshold theory Relation to surgical and medical treatment. J Reprod Med. 1998;43(3):287\u201392.","journal-title":"J Reprod Med"}],"updated-by":[{"DOI":"10.1007\/s12325-025-03464-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03397-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T06:32:52Z","timestamp":1766644372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03397-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3397"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03397-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12325-025-03464-5","URL":"https:\/\/doi.org\/10.1007\/s12325-025-03464-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kyoko Kikuno, Ryuta Asada, Takuma Ishihara, Ken-ichirou Morishige, Kenro Chikazawa, Tatsuro Furui, and Masanori Isobe declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study protocol was approved by the Clinical Research Review Committee of the Nagoya City University Hospital (approval number: 2021A001-23b001), and informed consent was obtained from all participants before study enrollment. This study adhered to the ethical principles of the Declaration of Helsinki. All data were anonymized to protect the participants\u2019 privacy. No personally identifiable information is included in the dataset. Additionally, stringent protective measures, e.g., encrypted data storage and restricted access protocols, were implemented to ensure data confidentiality. The protocol was finalized before enrollment began.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statements"}}]}}